Basit öğe kaydını göster

dc.contributor.authorGoker, Hakan
dc.contributor.authorKelkitli, Engin
dc.contributor.authorBuyukasik, Yahya
dc.contributor.authorDemiroglu, Haluk
dc.date.accessioned2020-06-21T13:11:23Z
dc.date.available2020-06-21T13:11:23Z
dc.date.issued2018
dc.identifier.issn1473-0502
dc.identifier.urihttps://doi.org/10.1016/j.transci.2018.04.013
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11686
dc.descriptionWOS: 000436914800007en_US
dc.descriptionPubMed: 29753698en_US
dc.description.abstractThe incidence of most hematologic malignancies increases with age. Physicians increasingly refer older patients for hematopoietic stem cell transplantation (HSCT) due to more experience and improved supportive care in HSCT. This article discusses the available data regarding the feasibility, tolerability, toxicity, and effectiveness of autologous and allogeneic HSCT in older adults.en_US
dc.language.isoengen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.isversionof10.1016/j.transci.2018.04.013en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAutologous hematopoietic stem cell transplantationen_US
dc.subjectAllogeneic hematopoietic stemcell transplantationen_US
dc.subjectGeriatric patientsen_US
dc.titleHematopoietic stem cell transplantation in geriatric patients in Turkeyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume57en_US
dc.identifier.issue2en_US
dc.identifier.startpage159en_US
dc.identifier.endpage162en_US
dc.relation.journalTransfusion and Apheresis Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster